Health Care & Life Sciences » Pharmaceuticals | Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals Inc. | Ownership

Companies that own Spectrum Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
13,872,435
13.33%
1,246,065
0.02%
06/30/2018
The Vanguard Group, Inc.
10,391,055
9.99%
320,122
0.01%
07/31/2018
PRIMECAP Management Co.
10,126,000
9.73%
2,706,000
0.15%
06/30/2018
Consonance Capital Management LP
6,963,756
6.69%
760,400
8.01%
06/30/2018
SSgA Funds Management, Inc.
5,275,272
5.07%
398,494
0.01%
06/30/2018
Eastern Capital Ltd.
4,737,307
4.55%
0
33.35%
10/31/2017
Fidelity Management & Research Co.
4,549,751
4.37%
-1,556,749
0.01%
06/30/2018
Renaissance Technologies LLC
3,517,400
3.38%
-2,062,600
0.08%
06/30/2018
venBio Select Advisor LLC
3,419,818
3.29%
3,419,818
2.5%
06/30/2018
FIAM LLC
1,497,353
1.44%
258,160
0.06%
06/30/2018

About Spectrum Pharmaceuticals

View Profile
Address
11500 South Eastern Avenue
Henderson Nevada 89052
United States
Employees -
Website http://www.sppirx.com
Updated 07/08/2019
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.